Clinical Trials Logo

Depressive Disorder, Major clinical trials

View clinical trials related to Depressive Disorder, Major.

Filter by:

NCT ID: NCT02838043 Completed - Depression Clinical Trials

The Efficacy, Safety, and Tolerability of Probiotics on the Mood and Cognition of Depressed Patients

Start date: August 2016
Phase: Phase 3
Study type: Interventional

This study will be an 8-week open-label pilot study examining subjective and objective changes in mood, anxiety, cognition, and sleep before and after the introduction of a probiotic supplement containing Lactobacillus helveticus and Bifidobacterium longum in 10 treatment-naïve participants diagnosed with major depressive disorder (MDD). In order to examine the full composition of the micro biome, the investigators will also be collecting and analyzing fecal samples as well as blood samples to examine changes in plasma levels of inflammatory markers, 5-HT, and tryptophan in order to look at possible underlying mechanisms of any changes seen.

NCT ID: NCT02837887 Completed - Clinical trials for Major Depressive Disorder

Computerized Cognitive Behavior Therapy in Treating Depression in Patients With Cancer

Start date: July 15, 2016
Phase: N/A
Study type: Interventional

This randomized clinical trial studies how well a computerized cognitive behavior therapy program works in treating depression in patients with cancer. The cognitive behavior therapy program uses a series of internet-delivered sessions intended to help patients identify and change problematic patterns of thinking and behavior that maintain depression.

NCT ID: NCT02830399 Completed - Clinical trials for Major Depressive Disorder

Clinical Trial on Efficacy of rTMS to Improve ECT in Treatment-Resistant Depression

STIMAGNECT
Start date: July 15, 2016
Phase: N/A
Study type: Interventional

It's a prospective, multicentric, randomized, controlled study concerning 56 patients with treatment-resistant depression (TRD). The main objective of this study was to evaluate the efficacy of priming repeated Transcranial Magnetic Stimulation (rTMS) sessions before Electroconvulsive therapy (ECT) for treatment of TRD patients. The primary outcome will be the depressive symptoms intensity measured with the Hamilton Rating Scale For Depression (HAMD-21 items) after 5 ECT. The secondary outcome is to evaluate the safety and most particularly the cognitive effects of this association.

NCT ID: NCT02829671 Completed - Clinical trials for Major Depressive Disorders

Loneliness and Occurrence of Suicide Attempts and Suicidal Ideas

SOLSTIS
Start date: October 11, 2016
Phase: N/A
Study type: Interventional

Suicide is a major health problem that causes annually a million death worldwide. Loneliness is known to be associated with suicidal ideation in minors and to be related with suicidal risk in elderly people. However little is known about this association in a middle-aged population. Loneliness is a modifiable factor with suitable psychotherapeutic measures, it is essential to improve the scientific and medical knowledge about the link between this feeling and suicide risk in a population of depressed patients in middle age. The main objective is the study of the relationship between loneliness and the occurrence of suicidal behavior (SB) in major depressed adult population over 12 months. The secondary objectives are: - Identification of risk factors (clinical, neuropsychological and biological) of the occurrence of SB within a clinical population and their interaction; - Identification of predictive factors (clinical, neuropsychological, biological) therapeutic response to antidepressant in the context of depression.

NCT ID: NCT02816138 Completed - Clinical trials for Major Depressive Disorder

Depressed Mood Improvement Through Nicotine Dosing (Depressed MIND Study)

Start date: October 2016
Phase: Phase 4
Study type: Interventional

Late-life depression is characterized by both affective (mood) symptoms and cognitive deficits. There is currently no intervention that may provide consistent benefits to both mood and cognitive performance. Agonist activity at the nicotinic acetylcholine receptors via transdermal nicotine patches may provide benefit to both mood and cognition, working through nicotine's effects on brain neural networks, specifically the cognitive control network and default mode network. In this initial pilot project, the investigators will test this hypotheses in 15 nonsmoking depressed elders with subjective cognitive impairment. Following baseline neuroimaging and cognitive testing, participants will receive 12 weeks of open-label transdermal nicotine. Afterwards, participants will repeat neuroimaging and cognitive assessments.

NCT ID: NCT02815813 Completed - Obesity Clinical Trials

Lifestyle Intervention for Young Adults With Serious Mental Illness

Start date: July 3, 2017
Phase: N/A
Study type: Interventional

This is a four year project evaluating the effectiveness of a group-based lifestyle intervention (PeerFIT) supported by mobile health (mHealth) technology and social media compared to Basic Education in fitness and nutrition supported by a wearable Activity Tracking device (BEAT) in achieving clinically significant improvements in weight loss and cardiorespiratory fitness in young adults with serious mental illness (SMI).

NCT ID: NCT02809677 Completed - Asthma Clinical Trials

Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators

Start date: June 2016
Phase: N/A
Study type: Interventional

The investigators propose a one-year, repeated measures, within-subject design to examine the impact of improved caregiver depression on child asthma outcomes. A cross-lagged panel modeling (CLPM) for longitudinal data will be fit using a maximum likelihood structural equation model (SEM) in order to explore longitudinal mediation between asthma outcomes (asthma control, spirometry, quality of life (QOL)) and depressive symptoms. CLPM will test whether caregiver improvement preceded child asthma improvement, and SEM will test whether improved adherence and/or decreased child anxiety/depression mediated the effect. The investigators considered a randomized control trial, but it would not be ethically acceptable to withhold medication from caregivers diagnosed with Major Depressive Disorder (MDD) for the proposed one-year duration of the study. It is unlikely that potential participants in the study would find this acceptable. Furthermore a controlled design is not necessary since the investigators are not testing the efficacy of antidepressants for depression, but rather the impact of improvement on caregiver depression on the child.

NCT ID: NCT02805881 Completed - Clinical trials for Major Depressive Disorder

Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD)

CTO-TNS
Start date: May 2016
Phase: N/A
Study type: Interventional

Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD)

NCT ID: NCT02805439 Completed - Clinical trials for Major Depressive Disorder

Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment

Start date: March 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of S47445 versus placebo as adjunctive treatment of Major Depressive Disorder in patients with an inadequate response to antidepressant therapy.

NCT ID: NCT02801513 Completed - Clinical trials for Major Depressive Disorder

Maintaining Mechanisms of Chronic Depression and Their Changeability

GetWell
Start date: September 2013
Phase: N/A
Study type: Interventional

Despite considerable progress in the understanding of depression, the treatment of those who have entered a chronic course of the disorder still represents a major challenge. In order to develop more effective interventions it is important to learn more about maintaining mechanisms and the ways in which these can be addressed. Recent research has outlined aberrations in neurophysiological parameters that may serve as risk factors underlying tendencies to engage in maladaptive responses to negative mood, and that may be particularly pronounced in patients with chronic depression. Initial evidence suggests that such deficits may not be easily amenable through established treatments. The current study investigated whether mental training using mindfulness mediation, as compared to an active control training, could alter these parameters in chronically depressed patients.